Adjuvant and salvage radiation therapy after prostatectomy: American society for radiation oncology/american urological association guidelines

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 5, 2013, Pages 822-828

  Valicenti, Richard K ^a   Thompson, Ian ^b   Albertsen, Peter ^c   Davis, Brian J ^d   Goldenberg, S Larry ^e   Wolf, J Stuart ^f   Sartor, Oliver ^g   Klein, Eric ^h   Hahn, Carol ⁱ   Michalski, Jeff ^j   Roach III, Mack ^k   Faraday, Martha M ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Four Oaks Inc ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; DISEASE CONTROL; ONCOLOGY; RADIATION EFFECTS; UROLOGY;

ADJUVANT RADIATION THERAPIES; ADJUVANT THERAPY; COCHRANE DATABASE; EVIDENCE-BASED; METHODS AND MATERIALS; RADIATION ONCOLOGY; RADICAL PROSTATECTOMY; SALVAGE RADIATION THERAPIES; SALVAGE THERAPY; SYSTEMATIC LITERATURE REVIEW;

RADIOTHERAPY;

ANDROGEN DEPRIVATION THERAPY; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL SOCIETY; PATIENT COUNSELING; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION RESPONSE; REVIEW; SALVAGE THERAPY; SEXUAL FUNCTION; SYSTEMIC THERAPY; URINE INCONTINENCE;

EID: 84880018909     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.05.029     Document Type: Review

References (37)

1. American Cancer Society: Prostate cancer key statistics. 2009. Available at: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer- key-statistics; Accessed November 3 2012.
2. C.L. Amling, M.L. Blute, and E.J. Bergstralh Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years J Urol 164 2000 101 105 (Pubitemid 30434268)
3. F.K. Chun, M. Graefen, and M. Zacharias Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer World J Urol 24 2005 273 280
4. M. Han, A.W. Partin, and C.R. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555 565 (Pubitemid 32916759)
5. F.J. Bianco Jr., P.T. Scardino, and J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 2005 83 94 (Pubitemid 41356564)
6. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Preoperative nomogram predicting for the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715 717 (Pubitemid 43821789)
7. P. Swindler, J.A. Eastham, and M. Ohori Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 174 2005 903 907 (Pubitemid 41140626)
8. P.A. Kupelian, J. Katcher, and H.S. Levin Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy Int J Radiat Oncol Biol Phys 377 1997 1043 1052 (Pubitemid 27230028)
9. H.M. Lee, M.J. Solan, and P. Lupinacci Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiation therapy Urology 64 2004 84 89 (Pubitemid 38887584)
10. M. Ohori, T.M. Wheeler, and M.W. Kattan Prognostic significance of surgical margins in radical prostatectomy specimens J Urol 154 1995 1818 1824
11. B.A. Lowe, and S.F. Lieberman Disease recurrence and progression in unrelated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy J Urol 158 1997 1452 1456 (Pubitemid 27391217)
12. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597 (Pubitemid 29211767)
13. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335 (Pubitemid 44749360)
14. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578 (Pubitemid 41140332)
15. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
16. J.R. Bernard Jr., S.J. Buskirk, and M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740
17. C. Cozzarini, F. Montorsi, and C. Fiorino Need for high radiation dose (greater-than or equal to 70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol 75 2009 966 974
18. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
19. A. Siegmann, D. Bottke, and J. Faehndrich Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study Strahlenther Onkol 187 2011 467 472
20. N. Ohri, A. Dicker, and E. Trabulsi Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modeling Eur J Cancer 48 2012 837 844
21. J.M. Michalski, C. Lawton, and I. El Naqa Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 76 2010 361 368
22. M.A. Sidhom, A.B. Kneebone, and M. Lehman Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group Radiother Oncol 88 2008 10 19
23. K.L. Wiltshire, K.K. Brock, and M.A. Haider Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy Int J Radiat Oncol Biol Phys 69 2007 1090 1099 (Pubitemid 47625838)
24. P. Poortmans, A. Bossi, and K. Vandeputte Guidelines for target volume definition in postoperative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group Radiother Oncol 84 2007 121 127 (Pubitemid 47284534)
25. M. Bolla, H. van Poppel, and B. Tombal Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomized controlled trial (EORTC trial 22911) Lancet 380 2012 2018 2027
26. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial J Urol 181 2009 956 962
27. P.C. Albertsen, J.A. Hanley, and D.F. Penson Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation J Urol 171 2004 2221 2225 (Pubitemid 38625438)
28. G.P. Swanson Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 J Clin Oncol 25 2007 2225
29. R. Shinghal, C. Yemoto, and J.E. McNeal Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy. Prostate-specific antigen Urology 61 2003 380 385 (Pubitemid 36206537)
30. Z.A. Dotan, F.J. Bianco Jr., and F. Rabbani Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy J Clin Oncol 23 2005 1962 1968 (Pubitemid 46211375)
31. S.A. Boorjian, R.J. Karnes, and P.L. Crispen Radiation therapy after radical prostatectomy: impact on metastasis and survival J Urol 182 2009 2708 2715
32. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769 (Pubitemid 351846851)
33. C.R. King The timing of salvage radiotherapy after radical prostatectomy: a systematic review Int J Radiat Oncol Biol Phys 84 2012 104 111
34. N. Ohri, A. Dicker, and E. Trabulsi Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modeling Eur J Cancer 48 2012 837 844
35. F. Alongi, C. Fiorino, and C. Cozzarini IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with postoperative adjuvant or salvage radiotherapy after radical prostatectomy Radiother Oncol 93 2009 207 212
36. A. Goenka, J.M. Magsanoc, and X. Pei Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy Eur Urol 60 2011 1142 1148
37. P. Ost, N. Lumen, and A.S. Goessaert High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after RP for rising or persisting prostate-specific antigen: 5-year results Eur Urol 60 2011 842 849